Your browser doesn't support javascript.
loading
Bone mineral density, kidney function and participant-reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir.
Campbell, Lucy; Ibrahim, Fowzia; Barbini, Birgit; Samarawickrama, Amanda; Orkin, Chloe; Fox, Julie; Waters, Laura; Gilleece, Yvonne; Tariq, Shema; Post, Frank A.
Afiliação
  • Campbell L; King's College London, London, UK.
  • Ibrahim F; King's College Hospital NHS Foundation Trust, London, UK.
  • Barbini B; King's College London, London, UK.
  • Samarawickrama A; King's College Hospital NHS Foundation Trust, London, UK.
  • Orkin C; Sexual Health South West London, London, UK.
  • Fox J; Queen Mary University of London and Barts Health NHS Trust, London, UK.
  • Waters L; King's College London, London, UK.
  • Gilleece Y; Guy's and St Thomas' Hospitals NHS Foundation Trust, London, UK.
  • Tariq S; Mortimer Market Centre, London, UK.
  • Post FA; University Hospitals Sussex NHS Trust, Brighton, UK.
HIV Med ; 23(4): 362-370, 2022 04.
Article em En | MEDLINE | ID: mdl-34866304

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article